CLEVELAND and BOSTON, Jan. 21, 2025 /PRNewswire/ — MPE Partners (“MPE” or “Morgenthaler Private Equity”) announced today an investment in SKB Cases (“SKB” or the “Company”), a leading manufacturer of specialty protective cases. SKB serves over 2,000 customers across the military & industrial, music & pro AV, and sports end markets. MPE’s investment positions SKB for… Continue reading MPE Partners Announces Investment in SKB Cases
Tag: Morgan
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Celsius Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – CELH
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Celsius Holdings, Inc. (“Celsius” or the “Company”) (NASDAQ: CELH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number,… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Celsius Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – CELH
Avianca Group Announces Supplement to Exchange Offer and Consent Solicitation Memorandum relating to the Exchange Offer for Any and All of its 9.000% Tranche A-1 Senior Secured Notes due 2028 and Related Consent Solicitation
BOGOTA, Colombia, Jan. 21, 2025 /PRNewswire/ — Avianca Group International Limited (“Avianca Group”) today announced that its subsidiary Avianca Midco 2 PLC (the “Company”) has supplemented and amended the Exchange Offer and Consent Solicitation Memorandum dated January 14, 2025, (the “Original Exchange Offer and Consent Solicitation Memorandum”) with respect to the previously announced (i) offer… Continue reading Avianca Group Announces Supplement to Exchange Offer and Consent Solicitation Memorandum relating to the Exchange Offer for Any and All of its 9.000% Tranche A-1 Senior Secured Notes due 2028 and Related Consent Solicitation
Kantar Group announces the proposed sale of Kantar Media
LONDON, Jan. 18, 2025 /PRNewswire/ –Kantar Group, a leading, global market research company based in London and portfolio company of Bain Capital, has announced today the proposed sale of Kantar Media to H.I.G. Capital, a leading global alternative investment firm with $67 billion of capital under management. The contemplated deal will mark a new chapter… Continue reading Kantar Group announces the proposed sale of Kantar Media
Data Center General Construction Market, 31% of Growth to Originate from North America, Technavio
NEW YORK, Jan. 17, 2025 /PRNewswire/ — The global data center general construction market size is estimated to grow by USD 19.95 billion from 2024 to 2028, according to Technavio. The market is estimated to grow at a CAGR of 10.39% during the forecast period. For comprehensive forecast and historic data on regions,market segments, customer landscape, and… Continue reading Data Center General Construction Market, 31% of Growth to Originate from North America, Technavio
Hugel vows to become global leader at J.P. Morgan Healthcare Conference
– Hugel CFO Eva Huang presents mid- to long-term growth strategy at the APAC Track – The medical aesthetics company aims to expand its presence in more than 80 toxin markets, 70 dermal filler markets, and more than 10 cosmetics markets by 2028 SAN FRANCISCO, Jan. 16, 2025 /PRNewswire/ — Hugel Inc., a leading global… Continue reading Hugel vows to become global leader at J.P. Morgan Healthcare Conference
LOTTE BIOLOGICS to Present at the 2025 J.P. Morgan Healthcare Conference
New CEO James Park Delivers First Presentation at J.P. Morgan Healthcare Conference on “Advancing as a Global CDMO Leader” Unveiling of Next-Generation ADC Platform ‘SoluFlex Link’: Enabling High-Potency, High-Yield ADC Development and Manufacturing Incheon Songdo Bio Campus Plant 1 Under Construction, Targeting Commercial Production by 2027 SEOUL, South Korea, Jan. 16, 2025 /PRNewswire/ — LOTTE… Continue reading LOTTE BIOLOGICS to Present at the 2025 J.P. Morgan Healthcare Conference
J.F. Lehman & Company Announces Promotions and Team Additions
NEW YORK, Jan. 15, 2025 /PRNewswire/ — J.F. Lehman & Company (“JFLCO”), a leading middle-market private investment firm focused exclusively on the aerospace, defense, maritime, government and environmental sectors, is pleased to announce several promotions and team additions. Promotions include Karina Perelmuter to Managing Director, Megan E. Kanefsky to Director, Bridget A. Harding to Vice… Continue reading J.F. Lehman & Company Announces Promotions and Team Additions
Depo-Provera Brain Tumor Litigation: All-Female Legal Team Takes on Devastating Female Health Issue
MINNEAPOLIS, Jan. 15, 2025 /PRNewswire/ — National personal injury law firm Pritzker Hageman has assembled an all-female legal team to pursue litigation on behalf of women who developed meningioma tumors after using Depo-Provera birth control injections. Attorneys Alicia Penner and Morgan Vanden Heuvel are currently representing a South Dakota woman who developed multiple meningiomas following years of receiving Depo-Provera injections. Penner… Continue reading Depo-Provera Brain Tumor Litigation: All-Female Legal Team Takes on Devastating Female Health Issue
J.F. Lehman & Company Announces Promotions and Team Additions
NEW YORK, Jan. 15, 2025 /PRNewswire/ — J.F. Lehman & Company (“JFLCO”), a leading middle-market private investment firm focused exclusively on the aerospace, defense, maritime, government and environmental sectors, is pleased to announce several promotions and team additions. Promotions include Karina Perelmuter to Managing Director, Megan E. Kanefsky to Director, Bridget A. Harding to Vice… Continue reading J.F. Lehman & Company Announces Promotions and Team Additions